Human trabecular bone‐derived osteoblasts support human osteoclast formation in vitro in a defined, serum‐free medium
- 30 November 2004
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 203 (3) , 573-582
- https://doi.org/10.1002/jcp.20255
Abstract
While it has been assumed that osteoblasts in the human support osteoclast formation, in vitro evidence of this is currently lacking. We tested the ability of normal human trabecular bone-derived osteoblasts (NHBCs) to support osteoclast formation from human peripheral blood mononuclear cells (PBMC) in response to treatment with either 1α,25-dihydroxyvitamin D3 (1,25D) or parathyroid hormone (PTH), using a serum-replete medium previously used to support human osteoclast formation on a stroma of murine ST-2 cells. Under these conditions, NHBC did not support osteoclast formation, as assessed by morphological, histochemical, and functional criteria, despite our previous results demonstrating a link between induction of RANKL mRNA expression and NHBC phenotype in these media. We next tested a defined, serum-free medium (SDM) on NHBC phenotype, their expression of RANKL and OPG, and their ability to support osteoclast formation. SDM, containing dexamethasone (DEX) and 1,25D, induced phenotypic maturation of NHBC, based on the expression of STRO-1 and the bone/liver/kidney isoform of alkaline phosphatase (AP). PTH as a single factor did not induce phenotypic change. 1,25D and DEX induced the greatest ratio of RANKL:OPG mRNA, predictive of supporting osteoclast formation. Consistent with this, co-culture of NHBC with CD14+ PBMC, or bone marrow mononuclear cell (BMMC), or CD34+ BMMC precursors in SDM + 1,25D + DEX, resulted in functional osteoclast formation. Osteoclast formation also occurred in PTH + DEX stimulated co-cultures. Interestingly, SDM supplemented with recombinant RANKL (25–100 ng/ml) and M-CSF (25 ng/ml), did not induce osteoclast formation from any of the osteoclast precursor populations in stromal-free cultures, unlike serum-replete medium. This study demonstrates that under the appropriate conditions, adult human primary osteoblasts can support de novo osteoclast formation, and this model will enable the detailed study of the role of both cell types in this process.Keywords
This publication has 40 references indexed in Scilit:
- Isolation of a Human Homolog of Osteoclast Inhibitory Lectin That Inhibits the Formation and Function of OsteoclastsJournal of Bone and Mineral Research, 2004
- The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone FormationJournal of Bone and Mineral Research, 2002
- The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-α, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cellsBone, 2001
- Importance of Membrane- or Matrix-Associated Forms of M-CSF and RANKL/ODF in Osteoclastogenesis Supported by SaOS-4/3 Cells Expressing Recombinant PTH/PTHrP ReceptorsJournal of Bone and Mineral Research, 2000
- Proteinase expression during differentiation of human osteoclasts in vitroJournal of Cellular Biochemistry, 2000
- Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiationJournal of Cellular Biochemistry, 1999
- Human osteoclasts derive from CD14‐positive monocytesBritish Journal of Haematology, 1999
- Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of BoneBiochemical and Biophysical Research Communications, 1998
- The Cell-surface Form of Colony-stimulating Factor-1 Is Regulated by Osteotropic Agents and Supports Formation of Multinucleated Osteoclast-like CellsPublished by Elsevier ,1998
- Growth hormone stimulates multinucleated cell formation in long-term bone marrow culturesEuropean Journal of Cell Biology, 1998